Trials / Unknown
UnknownNCT01781312
Probiotics in IgA Nephropathy
Proof-of-concept Study of Efficacy and Safety of Dietary Supplementation With Probiotics in IgAN Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Uppsala University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Recent studies have shown an increased gastrointestinal reactivity and increased intestinal permeability in IgA nephropathy (IgAN). Probiotic supplementation is known to impact the gastrointestinal immune system possibly by improvement of both the immunologic and the non-immunologic intestinal barrier. Probiotic supplementation should thus theoretically have an effect on IgAN. In this study the investigators will study the efficacy and safety of Lactobacillus reuteri.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ProTectis | |
| DIETARY_SUPPLEMENT | Gastrus |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2013-01-31
- Last updated
- 2013-01-31
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01781312. Inclusion in this directory is not an endorsement.